Compare HBCP & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HBCP | PACB |
|---|---|---|
| Founded | 1908 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 453.4M | 419.8M |
| IPO Year | 2008 | 2010 |
| Metric | HBCP | PACB |
|---|---|---|
| Price | $64.68 | $1.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $63.50 | $1.83 |
| AVG Volume (30 Days) | 142.5K | ★ 5.4M |
| Earning Date | 04-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | ★ 29.01 | N/A |
| EPS | ★ 5.87 | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | N/A | $11.32 |
| Revenue Next Year | $4.74 | $12.13 |
| P/E Ratio | $11.01 | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $42.75 | $0.85 |
| 52 Week High | $65.95 | $2.73 |
| Indicator | HBCP | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 67.28 | 52.13 |
| Support Level | $56.72 | $1.20 |
| Resistance Level | N/A | $1.51 |
| Average True Range (ATR) | 2.00 | 0.09 |
| MACD | 0.52 | 0.03 |
| Stochastic Oscillator | 84.18 | 63.89 |
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities.It is holding company for Home Bank, N.A. The principal sources of funds are customer deposits, repayments of loans, repayments of investments, and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.